As safe and effective gene-editing and gene-replacement therapies become more attainable, developing the delivery systems that ensure these treatments are equitably available will be equally essential.
Plamena Simeonova, MD
Advertisement
Articles by Plamena Simeonova, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves first treatment for thymidine kinase 2 deficiency
2
FDA news in pediatrics: October 2025
3
J&J submits sBLA for ustekinumab to treat children with ulcerative colitis 2 years and up
4
Top 5 pediatric health headlines you missed in October 2025
5
